Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Emerging role of stem cells and tissue engineering in oculoplastic surgery.

Saini M., Gaba S., Singh U., Saini K., Gupta PC., Singh M.

Laboratory Study on Chronic Wound, published in Indian J Ophthalmol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Indian J Ophthalmol (2026)
Country
India
Reported sample size
—
Source database
PubMed
PMID
42330206
DOI
10.4103/IJO.IJO_3200_25

Abstract (original English)

Advancements in stem-cell biology and tissue engineering (TE) are transforming the field of oculoplastic surgery by offering innovative solutions for eyelid, orbital, and periocular reconstruction. Stem cells, including mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and adipose-derived stem cells (ASCs), provide regenerative potential through their ability to differentiate into ocular adnexal tissues and modulate wound healing via paracrine effects. Tissue-engineered constructs, combining biocompatible scaffolds, cellular components, and growth factors, enable the development of functional replacements for eyelid skin, tarsus, conjunctiva, and lacrimal structures. These technologies enhance esthetic and functional outcomes, reduce donor-site morbidity, and may overcome limitations of traditional grafts and flaps. Current applications include periocular volume augmentation, eyelid reconstruction, and management of anophthalmic sockets, with ongoing research directed toward bioengineered lacrimal glands and dynamic eyelid substitutes. Although challenges remain, such as optimizing scaffold integration, vascularization, and long-term safety, stem-cell and TE approaches hold significant promise for personalized, restorative, and regenerative strategies in oculoplastic surgery.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research